6533b82efe1ef96bd1293dc0

RESEARCH PRODUCT

Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

Vieta EduardFerrán Catalá-lópezFerrán Catalá-lópezRafael Tabarés-seisdedosJane A. DriverJane A. DriverAlfonso ValenciaManuel RidaoBrian HuttonBrian HuttonJaume Forés-martosDiego Macías Saint-geronsRicard Gènova-malerasJose M ValderasAdolfo Alonso-arroyoAdolfo Alonso-arroyo

subject

medicine.medical_specialtyAnorexia NervosaEpidemiological studyMedicine (miscellaneous)lcsh:Medicine03 medical and health sciences0302 clinical medicineNeoplasmsEpidemiologymental disordersmedicineProtocolHumans030212 general & internal medicinePsychiatryCancerbusiness.industryIncidencelcsh:REating disorderCancerCáncermedicine.disease3. Good healthMeta-analysisSystematic reviewAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisCohortSystematic reviewbibliometríaObservational studybusinessPsychosocialanorexia nerviosaSystematic Reviews as Topic

description

BACKGROUND: Anorexia nervosa is characterized by a severe restriction of caloric intake, low body weight, fear of gaining weight or of becoming fat, and disturbance of body image. Pathogenesis of the disorder may include genetic predisposition, hormonal changes and a combination of environmental, psychosocial, and cultural factors. Cancer is the second leading cause of death worldwide. At present, no systematic reviews and meta-analyses have evaluated the risk of cancer in people with anorexia nervosa. The objective of this study will be to evaluate the association between anorexia nervosa and the risk of developing or dying from cancer. METHODS/DESIGN: This study protocol is part of a systematic collection and assessment of multiple systematic reviews and meta-analyses (umbrella review) evaluating the association of cancer and multiple central nervous system disorders. We designed a specific protocol for a new systematic review and meta-analysis of observational studies of anorexia nervosa with risk of developing or dying from any cancer. Data sources will be PubMed, Embase, Scopus, Web of Science, and manual screening of references. Observational studies (case-control and cohort) in humans that examined the association between anorexia nervosa and risk of developing or dying from cancer will be sought. The primary outcomes will be cancer incidence and cancer mortality in association with anorexia nervosa. Secondary outcomes will be site-specific cancer incidence and mortality, respectively. Screening of abstracts and full texts, and data abstraction will be performed by two team members independently. Conflicts at all levels of screening and abstraction will be resolved through discussion. The quality of studies will be assessed by using the Ottawa-Newcastle scale by two team members independently. Random effects models will be conducted where appropriate. Subgroup and additional analyses will be conducted to explore the potential sources of heterogeneity. The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used for determining the quality of evidence for cancer outcomes. DISCUSSION: Findings from this systematic review will inform an ongoing umbrella review on cancer and central nervous system disorders. Our systematic review and meta-analysis of observational studies will establish the extent of the epidemiological evidence underlying the association between anorexia nervosa and cancer. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017067462. Specific funding from the Generalitat Valenciana (PROMETEOII/2015/021) and CIBERSAM/Institute of Health Carlos III was received for this work. The funders were not involved in the design of the protocol or decision to submit the protocol for publication, nor will they be involved in any aspect of the conduct of the review. BH is supported by a New Investigator Award from the Canadian Institutes of Health Research and the Drug Safety and Effectiveness Network. MR is partially funded by the Spanish Health Services Research on Chronic Patients Network (REDISSEC)/Institute of Health Carlos III. The views expressed in this article are the views of the authors and may not be understood or quoted as being made on behalf of, or reflecting the position of, the funder(s) or any institution. Sí

10.1186/s13643-017-0540-5.http://hdl.handle.net/20.500.12105/8499